Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/1989
06/28/1989EP0322209A1 Compounds
06/28/1989EP0322153A2 Heterocyclic oxophtalazinyl acetic acids
06/28/1989EP0321940A2 An improved method for the preparation of natural human growth hormone in pure form
06/27/1989US4843093 Butyrolactone derivatives, process for production thereof and use therefor
06/27/1989US4843071 Method and composition for treating obesity, drug abuse, and narcolepsy
06/27/1989CA1256379A1 Hair growth stimulating agents and their use
06/27/1989CA1256378A1 Pharmaceutical composition containing at least one naphtalenic derivative as active principle
06/21/1989EP0321287A2 Inhibition of lipogenesis
06/21/1989EP0321221A2 Method for preventing or treating anxiety employing an ace inhibitor
06/21/1989EP0321128A1 Fatty acid compositions
06/21/1989EP0321090A2 Isoxazolidine-3,5-diones in the treatment of hyperlipidemia
06/21/1989EP0320967A2 ANF derivatives with novel bridging
06/21/1989EP0320935A2 Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist
06/21/1989EP0320817A1 2,3-Dihydro-2-phenyl-5-amino-alkyl-naphtho[2,1-b][1,4]thiazepinone derivatives
06/20/1989US4840970 Aqueous solution containing lipid-soluble pharmaceutical substance
06/20/1989US4840967 Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
06/20/1989US4840951 Novel naphthalene derivative
06/20/1989CA1256111A1 Benzodiioxinopyrrole derivatives
06/15/1989WO1989005295A1 Acyl derivatives of hydroxypyrimidines
06/15/1989WO1989005146A2 Method for treatment of dyslipidemia in humans
06/14/1989EP0320455A1 Araliphatyl aminoalcane diphosphonic acids
06/14/1989EP0320362A1 Use of 3-hydroxy-2-(4-methoxyphenyl)-5(2-methylamino-ethyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-one derivatives in the preparation of medicaments inhibiting the platelet aggregation factor
06/14/1989EP0320361A1 3-Hydroxy-2-(4-methoxyphenyl)-5(2-methylaminoethyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-one derivatives, their preparation and their use in therapy
06/14/1989EP0320207A2 Methods and compositions for activating the human insulin receptor kinase
06/14/1989EP0319963A1 Preparations of vitamin E for external use
06/14/1989EP0319645A1 Cationized polysaccharide derivatives with hypocholesterolemic activity
06/14/1989CN1033379A Acyl derivatives of hydroxy pyrimidines
06/13/1989US4839370 Novel derivatives of 3-aryl-3-cycloalkyl-piperidine-2,6-dione
06/13/1989US4839358 Alpha-mercaptomethyl-benzene propanamides, pharmaceutical compositions and use
06/13/1989CA1255694A1 Crystal modification of disodium 3-amino-1- hydroxypropane-1,1-diphosphonate
06/13/1989CA1255591A1 Saccharide digestion inhibiting composition
06/07/1989EP0319463A2 Use of 4H-benzo[4,5]cyclohepta[1,2-b]thiophene derivatives to effect monokine inhibition
06/07/1989EP0319412A1 2-Piperazinyl-2-oxo-ethylene-substituted flavonoid derivatives, processes for their preparation and pharmaceutical compositions containing them
06/07/1989EP0319288A2 dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
06/07/1989EP0319189A1 Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
06/07/1989EP0319170A2 Acyl derivatives of hydroxy pyrimidines
06/07/1989EP0319073A2 Cyclo-octane neuroprotective agents
06/07/1989EP0318902A2 Use of linear annelated tricyclics as inhibitors of erythrocyte aggregation
06/07/1989EP0318889A2 Method for treatment of dyslipidemia in humans
06/07/1989EP0318727A2 Aryloxphenylpropylamines and their preparation and use
06/07/1989CN1033276A Biphenyl derivative and process for preparing same
06/06/1989US4837319 1-substituted alkyl-1,2-dihydro-2-pyrazinone derivatives
06/06/1989US4837255 Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
06/06/1989US4837205 Prodrugs of antihypercholesterolemic compounds
06/06/1989CA1255304A1 Tetracyclic spiro-hydantoin aldose reductase inhibitors
06/06/1989CA1255299A1 Guanidinothiazole derivatives containing alkylene bridges, a process for their preparation and their use as medicaments
06/01/1989WO1989004825A1 New derivatives of cysteine, processes for their preparation and their use
06/01/1989WO1989004821A1 N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
05/1989
05/31/1989EP0318446A1 Amino acid composition for parenteral nutritional support
05/31/1989EP0318234A2 Improvements in or relating to selective serotonin uptake inhibitors
05/31/1989EP0318233A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors
05/31/1989EP0318191A1 Oral phosphate ion adsorbent
05/31/1989EP0318184A1 Acceleration of bone formation with GM-CSF
05/31/1989EP0318181A2 N-(Biphenylmethyl)-3-hydroxyglutaramic acids and derivatives as hypocholesterolemic agents
05/31/1989EP0318092A2 Novel beta-adrenergic agonists
05/31/1989EP0317845A2 Substituted hydroxyl amines
05/30/1989US4834982 Potassium-neutral salureticum with anti-hypertensive effect
05/24/1989EP0317540A1 Cysteine derivatives, processes for their preparation and their use
05/24/1989EP0317505A1 Azacycloalkylalkandiphosphonic acids
05/24/1989EP0317355A2 Dietary compositions and methods using bile salt-activated lipase
05/24/1989EP0316939A2 Biphenyl derivatives, preparation method, pharmaceutical compositions comprising them and use
05/24/1989EP0316852A2 Inhibitors of nonenzymatic cross-linking
05/24/1989CN1033000A Magnesium additive for nutrients, feed and medicaments
05/23/1989US4833258 Intermediates useful in the preparation of HMG-COA reductase inhibitors
05/23/1989US4833161 Antidiabetic agents, anticholesterol agents, antilipemic agents
05/23/1989US4833147 Antiperspirants
05/23/1989US4833146 Brains, blood disorders
05/23/1989US4833129 Hypocholesterolemically and/or hypotriglyceridemically active RNA fractions
05/23/1989CA1254559A1 Class of spiro-linked pyrrolidine-2,5-diones and preparations thereof
05/23/1989CA1254558A1 Pyrazolo¬4,3-d|pyrimidine derivative, process for its production, antihyperlipidemic agent containing it, its intermediate and process for the production of the intermediate
05/23/1989CA1254518A1 Composition and method for treating mammalian acidosis
05/18/1989WO1989004178A1 New therapeutical use of h2-receptor-blocking compounds
05/18/1989WO1989004173A1 Acceleration of bone formation with gm-csf
05/17/1989EP0316097A1 Naphtho(2,1-b)furan derivatives
05/17/1989EP0315913A1 Antiseborrhoic topical compositions
05/17/1989EP0315912A1 Sebosuppressive preparations
05/16/1989US4831045 Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient
05/16/1989US4831028 Novel benzothiazinone derivatives, processes for their preparation, medicaments containing them and their use
05/16/1989US4830967 Process for producing antibiotic A80438
05/16/1989US4830859 Process for lubricating water-soluble vitamin powders
05/16/1989CA1254210A1 TETRAHYDRO-.beta.-CARBOLINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
05/16/1989CA1254140A1 Clear micellized solutions of fat soluble essential nutrients
05/10/1989EP0315434A2 Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same
05/10/1989EP0315390A2 Novel 4-oxobenzotriazines and 4-oxoquinazolines
05/10/1989EP0315249A1 Phthalazineacetic acid composition and tablet
05/10/1989EP0315115A2 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives, process for producing them and use thereof
05/10/1989EP0315071A2 Benzocyclohepten derivatives, their preparation and utilisation for pharmaceutics
05/09/1989US4829076 Novel dihydropyridines having calcium antagonistic and antihypertensive activity
05/09/1989CA1253802A1 Chewable mineral supplement
05/05/1989WO1989003837A1 Acylated uridine and cytidine and uses thereof
05/05/1989WO1989003836A1 Factors associated with essential hypertension
05/05/1989WO1989003834A1 Substituted azacyclohexyl derivatives
05/05/1989WO1989003830A1 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss
05/05/1989WO1989003829A1 Omeprazole for treatment of diseases related to bone loss
05/05/1989WO1989003688A1 Amino acid composition for parenteral nutritional support and the use thereof
05/05/1989WO1989003685A1 Charmitol and its method of use as a food intake modifier
05/03/1989EP0314624A1 Substituted azacyclohexyl derivatives
05/03/1989EP0314042A2 Novel copolymers and superoxide dismutase modified with said copolymers
05/03/1989EP0314041A1 New rifamycin derivatives
05/03/1989CN1032659A Substituted tetralins, chromans and related compounds in treatment of asthma, arthritis and related diseases
1 ... 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 ... 1298